MENLO PARK, Calif., July 20, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. SGHT (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced the six-month results from the SAHARA randomized controlled trial (RCT). The…Read More
Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare Technology to Restasis for the Treatment of Dry Eye Sight Sciences NASDAQSGHT
